Comorbidity of chronic pain and depression in neurological patients
https://doi.org/10.14412/2074-2711-2013-2332
Abstract
The paper presents the literature review of chronic pain syndromes concurrent with depression. Chronic pain and depression have a mutual impact on clinical manifestation, course and treatment effectiveness in these patients. When there is a multitude of neurological, somatic, and autonomic disorders characteristic for the concurrence of pain and depression, understanding the nature of this comorbidity, as well as its diagnosis and treatment priorities assumes an importance. The complexity of detecting the affective symptoms proper in these patients determines less favorable outcomes, chronic persistent pain, the development of therapeutic resistance, and the risk of disease recurrence. The epidemiology and clinical manifestations of chronic pain and depression in the most common neurological diseases are discussed. The current concepts of the pathogenesis of comorbidity of chronic pain and depression and the problems of psychopharmacology are considered.
About the Author
Gyuzel Rafkatovna Tabeeva
Department of Nervous System Diseases, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. <div><p>Ayso-Mateos JL, Vazquez-Barquez JL, Dowrick C et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatr. 2001;179:308–16. DOI: 10.1192%2Fbjp.179.4.308.</p><p>Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R. The association of depression and painful physical symptoms - a review of European literature. Eur Psychiatry. 2006;21(6):379–88. DOI: 10.1016%2Fj.eurpsy.2005.12.003. Epub 2006 Jun 23.</p><p>Katona C, Peveler R, Dowrick C et al. Pain symptoms in depression: definition and clinical significance. Clin Med. 2005;5(4):390–5. DOI: 10.7861%2Fclinmedicine.5-4-390.</p><p>Дамулин ИВ. Особенности депрессии при неврологических заболеваниях. Журнал неврологии и психиатрии им. С.С.Корсакова. 2005;(10):55–6. [Damulin IV. Osobennosti depressii pri nevrologicheskikh zabolevaniyakh. Zhurnal nevrologii i psikhiatrii im. S.S.Korsakova. 2005;(10):55–6.]</p><p>Мосолов СН, Костюкова ЕГ, Городничев АВ и др. Клиническая эффективность и переносимость препарата эсциталопрам при лечении умеренной и тяжелой депрессии. Современная терапия психических расстройств. 2007;(2):42–7. [Mosolov SN, Kostyukova EG, Gorodnichev AV i dr. Klinicheskaya effektivnost' i perenosimost' preparata estsitalopram pri lechenii umerennoy i tyazheloy depressii. Sovremennaya terapiya psikhicheskikh rasstroystv. 2007;(2):42–7.]</p><p>Ustin T, Sartorius N. Preventive Services Task Forse: Guide to Clinical Preventive Services. 2nd ed. Washington, DC:US. Department of Health and Human Services; 1999.</p><p>Павленко СС, Тов НЛ. Исследование распространенности основных видов хронических болевых синдромов среди населения Новосибирска. Боль. 2003;(1):13–6. [Pavlenko SS, Tov NL. Issledovanie rasprostranennosti osnovnykh vidov khronicheskikh bolevykh sindromov sredi naseleniya Novosibirska. Bol'. 2003;(1):13–6.]</p><p>Воробьева ОВ. Клинические особенности депрессии в общемедицинской практике (по результатам программы «Компас»). Consilium Medicum. 2004;6(2):154–15. [Vorob'eva OV. Klinicheskie osobennosti depressii v obshchemeditsinskoy praktike (po rezul'tatam programmy «Kompas»). Consilium Medicum. 2004;6(2):154–15.]</p><p>Aguera L, Failde I, Cervilla JA et al. Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care. BMC Fam Pract. 2010;(11):17. DOI: 10.1186/1471-2296-11-17.</p><p>Ohayon MM. Specific Characteristics of the pain/depression association in the general population. J Clin Psychiatry. 2004;65 suppl 12:5–9.</p><p>Rijavec N, Grubic VN. Depression and pain: often together but still a clinical challenge – a review. Psychiatr Danub. 2012;24(4):346–52.</p><p>Geerlings SW, Twisk JW, Beekman AT et al. Longitudinal relationship between pain and depression in older adults: sex, age and pain disability. Soc Psychiatry Psychiatr Epidemiol. 2002;37(1):23–30. DOI: 10.1007%2Fs127-002-8210-2.</p><p>Robinson MJ, Edwards SE, Iyengar S et al. Depression and pain. Front Biosci (Landmark Ed). 2009;14:5031–51. DOI: 10.2741%2F3585.</p><p>Katon W. Panic disorder and somatization. Review of 55 cases. Am J Med. 1984;77:101–6.</p><p>Bair M, Robinson R, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45. DOI: 10.1001%2Farchinte.163.20.2433.</p><p>Husain MM, Rush AJ, Trivedi MH et al. Pain in depression: STAR*D study findings. J Psychosom Res. 2007;63(2):113–22. DOI: 10.1016%2Fj.jpsychores.2007.02.009.</p><p>Gureje O. Psychiatric aspects of pain. Curr Opin Psychiatry. 2007;20:42–6. DOI: 10.1097%2FYCO.0b013e328010ddf4.</p><p>Borsook D. Neurological diseases and pain. Brain. 2012:135(2);320–44. DOI: 10.1093%2Fbrain%2Fawr271.</p><p>Fishbain DA, Cutler R, Rosomoff HL. Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–37. DOI: 10.1097%2F00002508-199706000-00006.</p><p>Fishbain DA, Steele-Rosomoff R, Rosomoff HL. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8(2):77–85. DOI: 10.1097%2F00002508-199206000-00003.</p><p>Fishbain DA, Cutler RB, Rosomoff H, Steele-Rosomoff R. Comorbidity between psychiatric disorders and chronic pain. Curr Rev Pain. 1998;2(1):1–10. DOI: 10.1007%2Fs11916-998-0057-7.</p><p>Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRI. Br J Psychiatry Suppl. 1998;35:7–12.</p><p>Fishbain DA, Cutler RB, Cole B et al. Are patients with chronic low back pain or chronic neck pain fatigued? Pain Med. 2004;5(2):187–95. DOI: 10.1111%2Fj.1526-4637.2004.04026.x.</p><p>Williams AN, Hill P, Gunary R, Gratchley G. Sexual difficulties of chronic pain patients. Clin J Pain. 2001;17:138–45.</p><p>Waddell G, McCulloch JA, Kummel E, Venner RM. Nonorganic physical signs in low-back pain. Spine. 1980;5(2):117–25. DOI: 10.1097%2F00007632-198003000-00005.</p><p>Simuni T, Sethi K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol. 2008;64 Suppl 2:65–80. DOI: 10.1002/ana.21472.</p><p>Goldenberg DL. Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am J Med. 2010;123(8):675–82. DOI: 10.1016/j.amjmed.2010.01.014. Epub 2010 Jun 11.</p><p>Stahl SM. Stahl's Essential Psychopharmacology. 3rd ed. Cambridge: University Press; 2008.</p><p>Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: The neuronal basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504–14.</p><p>Breder CD, Conway CM. Pain systems: interface with the affective brain. Sadock BJ, Sadock AV, editors. Kaplan & Sadock’s Comprehensive textbook of psychiatry. Lippincott Williams & Wilkins; 2009. P. 341–5.</p><p>Strigo IA, Simmons AN, Matthews SC et al. Major depressive disorder is associated with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry. 2008;65(11):1275–84. DOI: 10.1001/archpsyc.65.11.1275.</p><p>Pittinger C, Durman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33(1):88–109. DOI: 10.1038%2Fsj.npp.1301574. Epub 2007 Sep 12.</p><p>Videbech P, Ravnklide B. Hippocampal volume and depression: a meta analysis of MRI studies. Am J Psychiatry. 2004;161(11):1957–66. DOI: 10.1176%2Fappi.ajp.161.11.1957.</p><p>Deak T, Bordner KA, McElderry NK et al. Stress-induced increases in hypothalamic IL-1: a systematic comparison of multiple stressor paradigms. Brain Res Bull. 2005;64(6):541–56.</p><p>Kim YK, Na KS, Shin KH et al. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(5):1044–53. DOI: 10.1016%2Fj.pnpbp.2007.03.004. Epub 2007 Mar 13.</p><p>Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chem Acta. 2006;364(1-2):82–90.DOI: 10.1016%2Fj.cca.2005.06.013. Epub 2005 Sep 1.</p><p>Arnow BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry. 2004;65 suppl 12:10–5.</p><p>Greden JF. Physical symptoms of depression: unmet needs. J Clin Psychiatry. 2003;64 suppl 7:5–11.</p><p>Chan HN, Fam J, Ng BY. Use of Antidepressants in the Treatment of Chronic Pain. Ann Acad Med Singapore. 2009;38(11):974–9.</p><p>Ettinger AB, Argoff CE. Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics. 2007;4(1):75–83. DOI: 10.1016%2Fj.nurt.2006.10.003.</p><p>Mercier A, Auger-Aubin I, Lebeau JP et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Family Practice. 2013;14:55. DOI: 10.1186/1471-2296-14-55.</p><p>Larson MJ, Miller K, Fleming KJ. Treatment with antidepressant medications in private health plans. Adm Policy Ment Health. 2007;34(2):116–26. DOI: 10.1007%2Fs10488-006-0088-5.</p><p>Bras M, Dordevic V, Gregurek R, Bulajic M. Neurobiological and clinical relationship between psychiatric disorders and chronic pain. Psychiatr Danub. 2010;22(2):221–26.</p><p>Leuchter AF, Husain MM, Cook IA et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relive Depression) report. Psychol Med. 2010;40(2):239–51. doi: 10.1017/S0033291709006035. Epub 2009 Jun 3.</p><p>Fishbain DA. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms. J Clin Psychiatry. 2009;70(7):e22. DOI: 10.4088%2FJCP.8001tx4c.</p><p>Marks DM, Shah MJ, Patkar AA et al. Serotonin-norepinephrine reaptake inhibitors for pain control: premise and promise. Curr Neuropharmacology. 2009;7(4):331–6. DOI: 10.2174/157015909790031201.</p><p>Белова НА. Эсциталопрам (ципралекс) в общей медицине (обзор литературы). Consilium Medicum. 2010;(2):52–4. [Belova NA. Estsitalopram (tsipraleks) v obshchey meditsine (obzor literatury). Consilium Medicum. 2010;(2):52–4.]</p><p>Незнанов НГ, Борцов АВ. Новое качество терапии расстройств тревожно-депрессивного спектра – эсциталопрам. Журнал неврологии и психиатрии им. С.С.Корсакова. 2005;105(2):79–84. [Neznanov NG, Bortsov AV. A new quality of the therapy of anxiety and depression – escitalopram. Neuroscience and Behavioral Physiology. 2005;105(2):79–84.]</p><p>Chen F, Larsen MB, Sanchez C, Wiborg O. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur Neuropsychopharmacol. 2005;15(2):193–8. DOI: 10.1016%2Fj.euroneuro.2004.08.008.</p><p>Wade A, Lemming MO, Hedegaard BK. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol. 2002;17(3):95–102. DOI: 10.1097%2F00004850-200205000-00001.</p><p>Montgomery S, Hansen T, Kasper S. Efficacy of escitalopram compared to citalopram: a meta-analysis. Int J Neuropsychopharmacol. 2011;14(2):261–68. DOI: 10.1017/S146114571000115X. Epub 2010 Sep 29.</p><p>Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin. 2009;25(1):161–75. DOI: 10.1185/03007990802622726.</p><p>Kirino E. Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability. Patient Prefer Adherence. 2012;6:853–61. DOI: 10.2147/PPA.S22495. Epub 2012 Dec 4.</p><p>Mazza M, Mazza O, Pazzaglia C et al. Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain. Expert Opin Pharmacother. 2010;11(7):1049–52. DOI: 10.1517/14656561003730413.</p></div><br />
Review
For citations:
Tabeeva G.R. Comorbidity of chronic pain and depression in neurological patients. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(3):4-12. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2332
Views: 1120
Email this article 